Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Dyne Therapeutics Announces Upcoming Presentation Highlighting Robust CNS Activity in Nonhuman Primates with its FORCE™ Platform at 2026 ASGCT Annual Meeting
-
Onterris Announces Timing of First Quarter 2026 Results
-
Babcock & Wilcox Sets First Quarter 2026 Conference Call and Webcast for Monday, May 11, 2026 at 5 p.m. ET
-
Benchmark Senior Living at Putnam Farm Assisted Living Community Named Among Nation's Best in 2026 U.S. News & World Report Senior Living Ratings
-
PACS Group, Inc. Announces Retirement of Co-Founder and CFO Mark Hancock
-
Johnson & Johnson to Participate in the Bernstein’s 42nd Annual Strategic Decisions Conference
-
Ten North Carolina Community Colleges Selected for $2.5 Million Careers Electric™ Training Network
-
Eight Student Teams Named National Winners of 34th Annual ExploraVision Competition
-
The Falls at Cordingly Dam Assisted Living Community Named Among Nation's Best in 2026 U.S. News & World Report Senior Living Ratings
-
Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease
-
Solid Waste Authority Approves 40-Year Master Plan to Solve the Solid Waste Crisis in Broward County
-
Editas Medicine to Present New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at Upcoming Scientific Conferences
-
CareRx Corporation to Host First Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026 at 8:30 a.m. ET
-
Freddie Mac Issues Monthly Volume Summary for March 2026
-
Benchmark Senior Living at Forge Hill Assisted Living Community Named Among Nation's Best in 2026 U.S. News & World Report Senior Living Ratings
-
Asgard Therapeutics announces oral presentation at ASGCT 2026, showcasing advanced preclinical data on AT-108 – its first-in-class, off-the-shelf, gene-based cancer immunotherapy
-
CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026
-
Rgenta Therapeutics Announces Two Oral Presentations Highlighting Proprietary RSwitch Technology at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting
-
Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting
-
Hyperscale Data Subsidiary Ault Global Commodities Announces First Silver Purchase
-
Umoja Biopharma Announces Unveiling of UB-VV500 in Upcoming Poster Presentation at the American Society of Gene & Cell Therapy Annual Meeting
-
Mirai Bio to Unveil Two Next Generation Programs for Targeted Nucleic Acid Delivery Beyond the Liver at ASGCT 2026
-
Encoded Therapeutics to Present ETX101 Data in Dravet Syndrome at the 2026 ASGCT Presidential Symposium
-
Apertura Gene Therapy and Scientists from the Broad Institute to Share Data on TfR1 CapX™, a Novel Capsid Targeting the Central Nervous System (CNS), at the American Society of Gene and Cell Therapy
-
Dyno Therapeutics to Present New Capsids and AI Advancements in Gene Delivery at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
-
Mission Bancorp Reports First Quarter Earnings of $7.7 Million, a 7% Increase Year Over Year, and Annual Loan Growth of 14.5%. Announces Extension of Stock Repurchase Plan and Declares 5.00% Annual St
-
Ellington Financial Announces Estimated Book Value Per Common Share as of March 31, 2026
-
Strand Therapeutics to Present Preclinical Data on Its Programmable mRNA In Vivo CAR-T Platform at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
-
Hillman Reports First Quarter 2026 Results
-
InTest Schedules First Quarter 2026 Financial Results Conference Call and Webcast
-
SmartRent Launches Value-Added Reseller Program
-
Phibro Animal Health Corporation Announces Regulatory Framework Change in Brazil for Antimicrobials
-
Matador Resources Company Announces Leadership Promotions
-
Sail Biomedicines to Present Preclinical Data Supporting Advancement of Its In Vivo eRNA™ CAR-T Product Candidate to the Clinic at ASGCT 2026 and TIDES USA 2026
-
Lifezone Announces Release Date of Q1 2026 Interim Financial Results and Notice of Investor Webcast
-
Dispatch Bio Presents SEND T Cell Armoring Strategy at ASGCT 2026 Annual Meeting
-
Tr1X to Present New Clinical and Preclinical Data on Engineered Tr1 Treg Cell Therapies at ASGCT 2026
-
AviadoBio Announces Agreement with Apertura Gene Therapy to License TfR1 CapX™, a Next-Generation Blood-Brain Barrier-Crossing Capsid
-
Nucor Reports Results for the First Quarter of 2026
-
Travere Therapeutics to Report First Quarter 2026 Financial Results
-
Rithm Capital’s Paramount Group Rebrands as Elecor Properties, a Premier Real Assets Platform Built for the Future of the Workplace
-
Addition Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting
-
420 with CNW — Illinois Disburses $32M to Cannabis Social Equity Firms
-
Montauk Renewables Schedules First Quarter 2026 Conference Call for Thursday, May 7, 2026, at 8:30 a.m. ET
-
Robin Energy Announces Final Results of Tender Offer for Common Shares
-
XCharge Files 2025 Annual Report on Form 20-F
-
Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting
-
Charlton Aria Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination
-
Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual Meeting
-
Gulf Resources, Inc. Receives NASDAQ Notice to Late Filing of Its Annual Report
